Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
FGFR1 overexpression
i
Other names:
FGFR1, BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM, Fibroblast growth factor receptor 1
Associations
(20)
News
Trials
C2 | Sensitive
C3 | Sensitive
D | Sensitive
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
FGF
Tyrosine Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
Cyclin Dependent Kinase Inhibitors
Other
PI3 Kinase Inhibitors
Cancel
Urothelial Cancer
Hormone Receptor Positive Breast Cancer
Lung Non-Small Cell Squamous Cancer
Non Small Cell Lung Cancer
HER2 Negative Breast Cancer
Hepatocellular Cancer
Liposarcoma
Gastric Cancer
Thyroid Gland Carcinoma
Bladder Cancer
Breast Cancer
Cholangiocarcinoma
Renal Cell Carcinoma
Lung Cancer
BAY 1163877
C3
FGFR1 overexpression
|
Urothelial Cancer
|
BAY 1163877
C3
FGFR1 overexpression
|
Lung Non-Small Cell Squamous Cancer
|
BAY 1163877
atezolizumab + BAY 1163877
C2
FGFR1 overexpression
|
Urothelial Cancer
|
atezolizumab + BAY 1163877
palbociclib + BAY 1163877
C3
FGFR1 overexpression
|
Hormone Receptor Positive Breast Cancer
|
palbociclib + BAY 1163877
alpelisib
D
FGFR1 overexpression
|
HER2 Negative Breast Cancer
|
alpelisib
lenvatinib
D
FGFR1 overexpression
|
Hepatocellular Cancer
|
lenvatinib
D
FGFR1 overexpression
|
Thyroid Gland Carcinoma
|
lenvatinib
erdafitinib
D
FGFR1 overexpression
|
Liposarcoma
|
erdafitinib
infigratinib
D
FGFR1 overexpression
|
Gastric Cancer
|
infigratinib
anlotinib
D
FGFR1 overexpression
|
Non Small Cell Lung Cancer
|
anlotinib
PRN1371
D
FGFR1 overexpression
|
Lung Non-Small Cell Squamous Cancer
|
PRN1371
TKI258
D
FGFR1 overexpression
|
Bladder Cancer
|
TKI258
PD173074
D
FGFR1 overexpression
|
Bladder Cancer
|
PD173074
palbociclib + ABSK091
D
FGFR1 overexpression
|
Breast Cancer
|
palbociclib + ABSK091
palbociclib
D
FGFR1 overexpression
|
Breast Cancer
|
palbociclib
NXP800
D
FGFR1 overexpression
|
Cholangiocarcinoma
|
NXP800
sorafenib
C3
FGFR1 overexpression
|
Renal Cell Carcinoma
|
sorafenib
ponatinib
C3
FGFR1 overexpression
|
Lung Cancer
|
ponatinib
M6123
D
FGFR1 overexpression
|
Non Small Cell Lung Cancer
|
M6123
FGFR inhibitor
D
FGFR1 overexpression
|
Breast Cancer
|
FGFR inhibitor
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
